Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01499563
Show Display Options
Rank Status Study
1 Completed Study of a Novel Antipsychotic ITI-007 in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: ITI-007;   Drug: Placebo;   Drug: Risperidone

Indicates status has not been verified in more than two years